Generics in France, MarketLine

Generics in France, MarketLine

  • August 2018 •
  • 37 pages •
  • Report ID: 4700389 •
  • Format: PDF
Generics in France

Generics in France industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2013-17, and forecast to 2022). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Essential resource for top-line data and analysis covering the France generics market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Key Highlights
- For the purposes of this profile, a generic drug is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both unbranded generics and all branded generics are included. However, off-patent drugs that continue to be offered by the original manufacturer under the original name, and which form part of the ’generic-eligible’ market, are not included.
- The French generics market had total revenues of $4bn in 2017, representing a compound annual growth rate (CAGR) of 0.5% between 2013 and 2017.
- Market consumption volume increased with a CAGR of 1% between 2013 and 2017, to reach a total of 80.8% in 2017.
- The French market has been relatively slow to adopt generics compared to other European countries, such as the UK and Germany, but recent changes to policies have meant that a slow uptake has been possible, and the value of the market has increased.

- Save time carrying out entry-level research by identifying the size, growth, and leading players in the generics market in France
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the generics market in France
- Leading company profiles reveal details of key generics market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the France generics market with five year forecasts by both value and volume

Reasons to buy
- What was the size of the France generics market by value in 2017?
- What will be the size of the France generics market in 2022?
- What factors are affecting the strength of competition in the France generics market?
- How has the market performed over the last five years?
- How large is France’s generics market in relation to its regional counterparts?

We are very sorry, but an error occurred.
Please contact if the problem remains.